Go to the list of all blogs
Allana's Avatar
published in Blogs
Aug 04, 2026
Why Is Albany International (AIN) Stock Down -14.58% Today?

Why Is Albany International (AIN) Stock Down -14.58% Today?

Key Takeaways

  • AIN shares plummeted approximately 14.58% in Tuesday's trading session, erasing months of gains in a single day.
  • Q2 2026 revenue missed Wall Street estimates, coming in at $329.5 million versus consensus expectations of approximately $339–$342 million, despite an EPS beat.
  • Q3 2026 guidance disappointed investors, with adjusted EPS projected at $0.60–$0.70, marking a sharp sequential decline from Q2's $0.82.
  • Machine Clothing segment headwinds, including an equipment failure and end-market softness, raised concerns about operational stability.
  • Analyst sentiment was already cautious heading into the report, with an average "Reduce" rating and price targets significantly below the pre-earnings trading level.
  • Traders are now watching whether the sell-off stabilizes near the 200-day moving average or if further downside emerges as institutions reassess positions.

Opening Summary

AIN, the stock of Albany International Corp. — a materials science and engineered components manufacturer serving the paper, pulp, aerospace, and defense industries — suffered a dramatic sell-off on Tuesday, falling approximately 14.58%. The shares were trading near $64.17, down sharply from the prior session's close of $75.12. The plunge came in reaction to the company's second-quarter 2026 earnings report, released before the market opened, which featured a revenue miss and softer-than-expected forward guidance that overshadowed an otherwise solid bottom-line performance.

Q2 Earnings: EPS Beat Overshadowed by Revenue Miss

Albany International reported adjusted earnings of $0.82 per share for the second quarter of 2026, topping the consensus analyst estimate of $0.71–$0.74 by a comfortable margin. Net income attributable to the company rose 90% year-over-year to $17.4 million, and adjusted EBITDA reached $57.8 million — the strongest level in two years. On the surface, the numbers appeared constructive: gross profit grew 10.7% to $107.9 million, and operating income surged 44.3% to $32.1 million, driven by cost containment initiatives and a favorable mix of aerospace and defense programs in the Engineered Composites segment.

However, the top line told a different story. Revenue of $329.5 million, while up 5.8% year-over-year, fell meaningfully short of the roughly $339–$342 million that analysts had projected. The shortfall was attributed to several discrete factors, including end-market softness in the Machine Clothing division and downtime related to an equipment failure in that same business. For a stock that had rallied nearly 50% year-to-date and was trading near the top of its 52-week range, the revenue disappointment gave investors a clear reason to take profits.

Disappointing Q3 Guidance Rattles Confidence

Perhaps the most damaging element of Tuesday's report was the forward outlook. Albany International issued third-quarter 2026 guidance calling for adjusted EPS in the range of $0.60 to $0.70 — a sequential decline of 15% to 27% from the $0.82 just reported. Consolidated revenue guidance of $320 million to $330 million also implied flat to modestly lower sequential revenue. The weaker guidance surprised investors who had expected continued momentum, particularly given the strength demonstrated in the Engineered Composites business, where revenue grew 14.2% year-over-year on a constant currency basis.

CEO Gunnar Kleveland acknowledged the mixed picture, stating that the quarter delivered the "strongest Adjusted EBITDA we have achieved in the past two years" but conceding that results came in with "modestly lower-than-expected revenue due to several discrete factors." CFO Will Station struck a measured tone, emphasizing "disciplined execution and a more focused operating model" but also noting a "fluid demand environment" across the geographies the company serves.

Machine Clothing Headwinds and Segment Dynamics

The Machine Clothing segment — Albany's legacy business producing custom-designed consumable belts for paper, pulp, and non-woven manufacturing — saw net revenues decline 2.4% on a constant currency basis. Cyclical softness in the Americas, compounded by an equipment failure that disrupted production, weighed on results. The segment's adjusted EBITDA margin slipped to 28.0% from 28.9% a year earlier, though on a constant currency basis margins edged slightly higher. These operational hiccups raised questions about near-term reliability in a division that has historically been a steady cash flow generator.

In contrast, the Engineered Composites segment continued to perform well, with revenue climbing 14.2% at constant currency behind strength in the LEAP commercial aerospace program and defense platforms including the CH-53K and missile programs. Adjusted EBITDA margin in the segment expanded to 13.3% from 8.5%, reflecting the benefits of scaling more profitable programs and a disciplined focus on quality of earnings. The sharp divergence between the two segments may prompt investors to reassess the sum-of-the-parts valuation.

Market Context and Trading Activity

The magnitude of Tuesday's sell-off was amplified by the stock's elevated positioning heading into the report. AIN had rallied roughly 50% year-to-date and was trading near its 52-week high of $77.00 before the release, leaving little room for error. Pre-existing analyst skepticism — with an average "Reduce" rating and a consensus price target hovering near $54.00, more than 25% below the pre-earnings level — suggested that Wall Street had been bracing for a potential reset. The earnings release appeared to validate those concerns.

Trading volume surged well above the daily average as the stock sliced through both its 50-day moving average near $71.66 and approached its 200-day moving average around $62.19. The breach of these key technical levels likely triggered additional selling from momentum-oriented and systematic strategies. Broader industrial and aerospace sector ETFs were not under comparable pressure, confirming that the move was company-specific rather than macro-driven.

What Comes Next for AIN

Attention now turns to whether AIN can stabilize around current levels. The 200-day moving average near $62 represents a critical technical support zone; a decisive break below that threshold could invite another wave of selling. Albany's management team maintained its full-year growth trajectory expectations and highlighted a "well-positioned" outlook for the balance of 2026, but the burden of proof has shifted to execution in the second half.

Investors will monitor upcoming quarterly reports for signs that the Machine Clothing equipment failure was truly a one-time event and that end-market demand stabilizes across all geographies. The Engineered Composites business remains a bright spot, with multiple defense and commercial aerospace programs continuing to scale. Key risks include further disruptions in Machine Clothing, any softening in aerospace demand, and currency headwinds from a weaker U.S. dollar. With institutional ownership at approximately 97%, shifts in positioning by large shareholders could also drive outsized moves in either direction.

Trending AI Robots

For traders seeking to navigate volatile market environments with data-driven precision, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to adapt to evolving market conditions. Tickeron features hundreds of AI trading bots spanning thousands of tickers, but only the strongest performers under current market dynamics are highlighted in this trending section. Each bot varies by strategy, timeframe, performance metrics, and traded symbols, allowing users to explore automated approaches that align with their trading objectives. Explore the Trending AI Robots to see which strategies are delivering results right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AIN

AIN's RSI Oscillator dives oversold zone

The RSI Oscillator for AIN moved into overbought territory on August 04, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AIN advanced for three days, in of 335 cases, the price rose further within the following month. The odds of a continued upward trend are .

AIN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 219 cases where AIN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where AIN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AIN as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AIN turned negative on July 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

AIN moved below its 50-day moving average on August 04, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AIN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.395) is normal, around the industry mean (3.347). P/E Ratio (27.159) is within average values for comparable stocks, (122.755). AIN's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (6.287). P/S Ratio (1.471) is also within normal values, averaging (2.601).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AIN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AIN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

Industry description

The textiles industry includes companies that spin fiber and weave fabrics into raw products such as polyester filaments and staple yarns that are manufactured into finished products. Albany International Corp., Unifi, Inc. and Culp, Inc. are some of the major players in this business.

Market Cap

The average market capitalization across the Textiles Industry is 425.34M. The market cap for tickers in the group ranges from 1.12K to 10.82B. TRYIF holds the highest valuation in this group at 10.82B. The lowest valued company is UNIR at 1.12K.

High and low price notable news

The average weekly price growth across all stocks in the Textiles Industry was -2%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 10%. PASW experienced the highest price growth at 5%, while AIN experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Textiles Industry was -9%. For the same stocks of the Industry, the average monthly volume growth was 228% and the average quarterly volume growth was 109%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 66
Price Growth Rating: 51
SMR Rating: 78
Profit Risk Rating: 100
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
AIN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a producer of paper machine clothing

Industry Textiles

Profile
Details
Industry
Textiles
Address
216 Airport Drive
Phone
+1 603 330-5800
Employees
5600
Web
https://www.albint.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.